GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vectus Biosystems Ltd (ASX:VBS) » Definitions » Price-to-Free-Cash-Flow

Vectus Biosystems (ASX:VBS) Price-to-Free-Cash-Flow : N/A (As of Jul. 19, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Vectus Biosystems Price-to-Free-Cash-Flow?

As of today (2024-07-19), Vectus Biosystems's share price is A$0.082. Vectus Biosystems's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.03. Hence, Vectus Biosystems's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Vectus Biosystems's Price-to-Free-Cash-Flow or its related term are showing as below:

ASX:VBS's Price-to-Free-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 33.27
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Vectus Biosystems's Free Cash Flow per Share for the six months ended in Dec. 2023 was A$-0.02. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was A$-0.03.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was 27.40% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was -6.60% per year.

During the past 8 years, Vectus Biosystems's highest 3-Year average Free Cash Flow per Share Growth Rate was 30.70% per year. The lowest was -43.90% per year. And the median was 8.70% per year.


Vectus Biosystems Price-to-Free-Cash-Flow Historical Data

The historical data trend for Vectus Biosystems's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vectus Biosystems Price-to-Free-Cash-Flow Chart

Vectus Biosystems Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial - - - - -

Vectus Biosystems Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Vectus Biosystems's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, Vectus Biosystems's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vectus Biosystems's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vectus Biosystems's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Vectus Biosystems's Price-to-Free-Cash-Flow falls into.



Vectus Biosystems Price-to-Free-Cash-Flow Calculation

Vectus Biosystems's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=0.082/-0.026
=N/A

Vectus Biosystems's Share Price of today is A$0.082.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Vectus Biosystems's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was A$-0.03.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Vectus Biosystems  (ASX:VBS) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Vectus Biosystems Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Vectus Biosystems's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Vectus Biosystems (ASX:VBS) Business Description

Traded in Other Exchanges
N/A
Address
3-11 Primrose Avenue, Rosebery, Sydney, NSW, AUS, 2018
Vectus Biosystems Ltd is an emerging biotechnology company based in Sydney, Australia. The company is in the process of developing a treatment for fibrosis and high blood pressure, which includes heart, kidney, and liver diseases. The company has also developed a technology aimed at improving the speed and accuracy of measuring the amount of DNA and RNA in samples tested in laboratories.

Vectus Biosystems (ASX:VBS) Headlines

No Headlines